149 related articles for article (PubMed ID: 17127239)
1. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice.
Gonzalez-Navarro H; Vila-Caballer M; Pastor MF; Vinue A; White MF; Burks D; Andres V
Front Biosci; 2007 Jan; 12():2291-8. PubMed ID: 17127239
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling.
González-Navarro H; Vinué A; Vila-Caballer M; Fortuño A; Beloqui O; Zalba G; Burks D; Díez J; Andrés V
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2187-94. PubMed ID: 18802016
[TBL] [Abstract][Full Text] [Related]
3. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.
Jun JY; Ma Z; Pyla R; Segar L
Atherosclerosis; 2012 Dec; 225(2):341-7. PubMed ID: 23099119
[TBL] [Abstract][Full Text] [Related]
4. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
[TBL] [Abstract][Full Text] [Related]
5. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/Lymphotoxin β-Receptor pathway.
Andrés-Blasco I; Vinué Á; Herrero-Cervera A; Martínez-Hervás S; Nuñez L; Piqueras L; Ascaso JF; Sanz MJ; Burks DJ; González-Navarro H
Thromb Haemost; 2016 Aug; 116(2):379-93. PubMed ID: 27172975
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
Clough MH; Schneider DJ; Sobel BE; White MF; Wadsworth MP; Taatjes DJ
J Histochem Cytochem; 2005 May; 53(5):603-10. PubMed ID: 15872053
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
Li J; Wang Q; Chai W; Chen MH; Liu Z; Shi W
Cardiovasc Diabetol; 2011 Dec; 10():117. PubMed ID: 22204493
[TBL] [Abstract][Full Text] [Related]
8. Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance.
Taberner-Cortés A; Vinué Á; Herrero-Cervera A; Aguilar-Ballester M; Real JT; Burks DJ; Martínez-Hervás S; González-Navarro H
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287201
[TBL] [Abstract][Full Text] [Related]
9. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
[TBL] [Abstract][Full Text] [Related]
10. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
[TBL] [Abstract][Full Text] [Related]
11. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
12. Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.
Chen K; Yuan R; Zhang Y; Geng S; Li L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396568
[TBL] [Abstract][Full Text] [Related]
13. Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1.
Galkina EV; Butcher M; Keller SR; Goff M; Bruce A; Pei H; Sarembock IJ; Sanders JM; Nagelin MH; Srinivasan S; Kulkarni RN; Hedrick CC; Lattanzio FA; Dobrian AD; Nadler JL; Ley K
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):247-56. PubMed ID: 22199371
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.
Rask-Madsen C; Buonomo E; Li Q; Park K; Clermont AC; Yerokun O; Rekhter M; King GL
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1124-31. PubMed ID: 22426129
[TBL] [Abstract][Full Text] [Related]
15. The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.
Vinué Á; Navarro J; Herrero-Cervera A; García-Cubas M; Andrés-Blasco I; Martínez-Hervás S; Real JT; Ascaso JF; González-Navarro H
Diabetologia; 2017 Sep; 60(9):1801-1812. PubMed ID: 28608285
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
Kawashima Y; Chen J; Sun H; Lann D; Hajjar RJ; Yakar S; Leroith D
Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets.
Lohmann C; Schäfer N; von Lukowicz T; Sokrates Stein MA; Borén J; Rütti S; Wahli W; Donath MY; Lüscher TF; Matter CM
Atherosclerosis; 2009 Dec; 207(2):360-7. PubMed ID: 19481752
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
19. Gal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet.
Lee SM; Lee YJ; Choi JH; Kho MC; Yoon JJ; Shin SH; Kang DG; Lee HS
BMC Complement Altern Med; 2014 Nov; 14():453. PubMed ID: 25416139
[TBL] [Abstract][Full Text] [Related]
20. Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis.
Jun JY; Ma Z; Segar L
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E145-54. PubMed ID: 21447785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
